Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02197169 : DNX-2401 With Interferon Gamma (IFN-?) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
PhasePhase 1
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Glioblastoma or gliosarcoma in first or second recurrence only

- Documented tumor recurrence or progression after failing prior surgical resection,
chemotherapy, or radiation

- Tumor size greater than or equal to 1.0 cm in two perpendicular diameters

- Not undergoing surgical resection or for whom gross total resection is not possible

- Karnofsky Performance Status greater than or equal to 70%

Exclusion Criteria:

- Multiple intracranial malignant glioma lesions

- Tumor location or involvement that would result in risk of ventricular penetration
during tumor injection

- Tumor involving both hemispheres or that which involves the subependyma or suspected
cerebrospinal fluid dissemination

- Tumor involving brain stem

- Documented extracranial metastasis

- Inability to undergo MRI

- Pregnant or nursing females

- Any medical condition that precludes the surgery necessary to administer DNX-2401
into the tumor using the cannula

- Immunocompromised subjects or those with autoimmune conditions, active hepatitis or
positive for human immunodeficiency virus (HIV)

- Li-Fraumeni Syndrome

Other protocol-defined inclusion/exclusion criteria may apply as outlined in the relevant
protocol version
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02197169      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740